Zacks Investment Research cut shares of American Vanguard Corporation (NYSE:AVD) from a buy rating to a hold rating in a research report sent to investors on Tuesday morning.

According to Zacks, “AMERICAN VANGUARD CORP. is a holding company, which through its subsidiaries, is engaged in the manufacturer and formulation of chemicals for crops, human and animal health protection. These chemicals which include insecticides, fungicides, molluscicides, growth regulatorsain, and soil fumigants, are marketed in liquid, powder, and granular forms. “

AVD has been the topic of a number of other research reports. BidaskClub raised shares of American Vanguard Corporation from a strong sell rating to a sell rating in a report on Thursday, August 10th. Roth Capital set a $28.00 price objective on shares of American Vanguard Corporation and gave the stock a buy rating in a research report on Sunday. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of Hold and an average price target of $22.67.

American Vanguard Corporation (NYSE AVD) traded up 0.06% on Tuesday, reaching $23.70. 12,594 shares of the company’s stock were exchanged. American Vanguard Corporation has a 12 month low of $14.20 and a 12 month high of $23.80. The firm has a market cap of $705.86 million, a PE ratio of 48.37 and a beta of 1.26. The firm’s 50-day moving average is $20.85 and its 200-day moving average is $18.39.

American Vanguard Corporation (NYSE:AVD) last posted its earnings results on Monday, July 31st. The basic materials company reported $0.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.14 by $0.01. The company had revenue of $77.90 million during the quarter, compared to analysts’ expectations of $77.71 million. American Vanguard Corporation had a net margin of 4.56% and a return on equity of 5.10%. American Vanguard Corporation’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the company posted $0.11 EPS. On average, equities analysts forecast that American Vanguard Corporation will post $0.65 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “American Vanguard Corporation (AVD) Downgraded to Hold at Zacks Investment Research” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another website, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/04/american-vanguard-corporation-avd-downgraded-to-hold-at-zacks-investment-research.html.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 19th. Shareholders of record on Thursday, October 5th will be issued a $0.015 dividend. This represents a $0.06 dividend on an annualized basis and a yield of 0.25%. The ex-dividend date of this dividend is Wednesday, October 4th. American Vanguard Corporation’s dividend payout ratio is 12.00%.

In other news, insider David` T. Johnson sold 6,000 shares of American Vanguard Corporation stock in a transaction on Monday, July 17th. The stock was sold at an average price of $19.00, for a total transaction of $114,000.00. Following the completion of the sale, the insider now owns 35,040 shares of the company’s stock, valued at $665,760. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. 4.70% of the stock is currently owned by company insiders.

Several hedge funds have recently added to or reduced their stakes in AVD. Kennedy Capital Management Inc. increased its position in American Vanguard Corporation by 1,158.7% during the second quarter. Kennedy Capital Management Inc. now owns 374,744 shares of the basic materials company’s stock worth $6,464,000 after acquiring an additional 344,971 shares during the period. JPMorgan Chase & Co. raised its stake in American Vanguard Corporation by 106.1% in the 1st quarter. JPMorgan Chase & Co. now owns 539,145 shares of the basic materials company’s stock worth $8,949,000 after purchasing an additional 277,593 shares in the last quarter. Walthausen & Co. LLC raised its stake in American Vanguard Corporation by 57.7% in the 2nd quarter. Walthausen & Co. LLC now owns 701,722 shares of the basic materials company’s stock worth $12,105,000 after purchasing an additional 256,637 shares in the last quarter. Heartland Advisors Inc. raised its stake in American Vanguard Corporation by 32.6% in the 2nd quarter. Heartland Advisors Inc. now owns 871,469 shares of the basic materials company’s stock worth $15,033,000 after purchasing an additional 214,141 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in American Vanguard Corporation by 5.2% in the 1st quarter. Vanguard Group Inc. now owns 2,430,201 shares of the basic materials company’s stock worth $40,342,000 after purchasing an additional 119,462 shares in the last quarter. Institutional investors and hedge funds own 76.87% of the company’s stock.

About American Vanguard Corporation

American Vanguard Corporation operates as a holding company. The Company conducts its business through its subsidiaries, AMVAC Chemical Corporation (AMVAC), GemChem, Inc (GemChem), 2110 Davie Corporation (DAVIE), Quimica Amvac de Mexico SA de C.V. (AMVAC M), AMVAC Mexico Sociedad de Responsabilidad Limitada (AMVAC M Srl), AMVAC de Costa Rica Sociedad de Responsabilidad Limitada (AMVAC CR Srl), AMVAC Switzerland GmbH (AMVAC S), AMVAC do Brasil Representacoes Ltda (AMVAC B), AMVAC C.V.

Receive News & Stock Ratings for American Vanguard Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard Corporation and related stocks with our FREE daily email newsletter.